CHGCY(CHGCY)
CHGCY
No analyst ratings available
No analyst price targets available for CHGCY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.42T | $1.67T |
| Low | $1.40T | $1.64T |
| High | $1.46T | $1.72T |
| EBITDA Avg | $657.50B | $772.53B |
| Low | $645.87B | $758.86B |
| High | $677.19B | $795.66B |
| EBIT Avg | $618.50B | $726.70B |
| Low | $607.55B | $713.84B |
| High | $637.02B | $748.46B |
| Net Income Avg | $500.96B | $654.31B |
| Low | $489.43B | $639.26B |
| High | $520.46B | $679.79B |
| EPS Avg | $152.20 | $198.79 |
| Low | $148.70 | $194.22 |
| High | $158.13 | $206.53 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $336.69B |
| Low | $331.88B |
| High | $345.91B |
| EBITDA Avg | $155.84B |
| Low | $153.62B |
| High | $160.11B |
| EBIT Avg | $146.60B |
| Low | $144.50B |
| High | $150.61B |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 3 / — |